Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters









Publication year range
1.
Gastritis grave inducida por pembrolizumab en un paciente con adenocarcinoma de pulmón / Severe pembrolizumab-induced gastritis in a patient with lung adenocarcinoma
Pérez Santamaría, Cristina; Castillo-López, Guillermo; Curto García, Isabel; Gómez Iglesias, Patricia; Lumbreras Cabrera, Mercedes; Carreira Guillán, Lourdes.
Rev. esp. enferm. dig ; 114(2): 127-128, febrero 2022. ilus
Article in Spanish | IBECS | ID: ibc-205569

Subject(s)
Humans , Male , Aged , Adenocarcinoma of Lung/chemically induced , Adenocarcinoma of Lung/drug therapy , Antibodies, Monoclonal, Humanized/adverse effects , Gastritis/chemically induced , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology
2.
Severe pembrolizumab-induced gastritis in a patient with lung adenocarcinoma.
Pérez Santamaría, Cristina; Castillo-López, Guillermo; Curto García, Isabel; Gómez Iglesias, Patricia; Lumbreras Cabrera, Mercedes; Carreira Guillán, Lourdes.
Rev Esp Enferm Dig ; 114(2): 127-128, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34743523

ABSTRACT

Cancer immunotherapy is an increasingly common treatment option based on anti-tumor immune response. However, a challenge is arising regarding its potential, which is the poorly understood recognized immune-mediated adverse effects.


Subject(s)
Adenocarcinoma of Lung , Gastritis , Lung Neoplasms , Adenocarcinoma of Lung/chemically induced , Adenocarcinoma of Lung/drug therapy , Antibodies, Monoclonal, Humanized/adverse effects , Gastritis/chemically induced , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL